Life Sciences Portfolio (LS)

The objective of this portfolio is to pursue maximum capital appreciation by focusing on core positions of healthcare companies across three strategies of life science:

  •    Developmental Stage Biotechnologies
  •    Diabetes Tools & Management Companies
  •    Large Cap Healthcare Companies

We take a fundamental approach to security selection based on our opinion of a company’s growth potential, while taking into consideration its company specific risk.

We believe this can help to dampen the overall volatility in the healthcare sector.
Investors have the option to select allocation percentages within each strategy.

 *The PIM program may not be suitable for all investors. Please carefully review the Wells Fargo Advisors disclosure for a full description of our services. The minimum account size for this program is $50,000.